SCHEMBL917535

SCHEMBL917535

CCCCCCOc1ccc(Br)cc1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR5A1 Q13285 1/20 0.66
LTA4H P09960 4/20 0.58
TP53 P04637 2/20 0.58
TSHR P16473 1/20 0.58
PLA2G4B P0C869 3/20 0.56
RARB P10826 3/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
ALOX15 P16050 1/20 0.53
RAB9A P51151 1/20 0.53
HSD17B10 Q99714 1/20 0.53
DRD2 P14416 1/20 0.51
DRD4 P21917 1/20 0.51
DRD3 P35462 1/20 0.51
PLA2G4A P47712 1/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7474073 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL5599235 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL8215140 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL6740617 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL4800857 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL917687 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL8216305 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL1102341 1.00 NR5A1 (0.66) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL917938 0.98 NR5A1 (0.62) NR5A1LTA4HTP53TSHRPLA2G4B
SCHEMBL7697448 0.94 RARB (0.61) NR5A1LTA4HTP53TSHRPLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119708007-B Near infrared emission aggregation-induced emission organic photo-thermal molecule and preparation method and application thereof 香港中文大学(深圳) 2025-06-13 CN claimed
CN-119708007-B Near infrared emission aggregation-induced emission organic photo-thermal molecule and preparation method and application thereof 香港中文大学(深圳) 2025-06-13 CN disclosed
CN-119735602-A Triazolothiazine dioxide compound, photoelectric device and display device TCL科技集团股份有限公司 2025-04-01 CN disclosed
CN-119708007-A Near infrared emission aggregation-induced emission organic photo-thermal molecule and preparation method and application thereof 香港中文大学(深圳) 2025-03-28 CN disclosed
EP-4371982-A2 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX Pharmaceuticals, Inc. (US) 2024-05-22 EP disclosed
EP-3583096-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2024-03-27 EP disclosed
US-20230391798-A1 DONOR-ACCEPTOR-DONOR TYPE MATERIALS FOR OPTOELECTRONIC APPLICATIONS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2023-12-07 US disclosed
CN-117143118-A Donor-acceptor-donor materials for optoelectronic applications 南加州大学 2023-12-01 CN disclosed
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
US-5211879-A ESTER COMPOUNDS AND LIQUID CRYSTAL COMPOSITIONS CONTAINING THE SAME NIPPON MINING CO., LTD. (JP) 1993-05-18 US disclosed
EP-0329752-B1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK PATENT GmbH (DE) 1993-03-17 EP disclosed
US-5082587-A ACHIRAL FLUORINE-CONTAINING LIQUID CRYSTALS 3M INNOVATIVE PROPERTIES COMPANY 1992-01-21 US disclosed
EP-0427166-A1 Ester compounds and liquid crystal compositions containing the same JAPAN ENERGY CORPORATION (JP) 1991-05-15 EP disclosed
EP-0360521-A2 Achiral fluorine-containing liquid crystals MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1990-03-28 EP disclosed
EP-0360042-A1 p-Terphenyl derivatives and liquid crystalline compositions KANTO KAGAKU KABUSHIKI KAISHA (JP) 1990-03-28 EP disclosed
US-4879060-A 2-phenylpyridine derivatives and liquid crystal compositions including same SEIKO EPSON KABUSHIKI KAISHA (JP) 1989-11-07 US disclosed
EP-0329752-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK PATENT GmbH (DE) 1989-08-30 EP disclosed
WO-1989002425-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-03-23 WO disclosed
US-4684220-A 2-phenylpyridine derivatives and liquid crystal compositions including same SEIKO EPSON KABUSHIKI KAISHA (JP) 1987-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391798-A1 DONOR-ACCEPTOR-DONOR TYPE MATERIALS FOR OPTOELECTRONIC APPLICATIONS ALDH1A2, SLC19A2, SLCO1B3 NR5A1 3613/4885LTA4H 937/4885TP53 4765/4885
US-20230133667-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC NR5A1 3703/4885LTA4H 3475/4885TP53 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.